4-Methylaminopyridine is a non-selective iNOS inhibitor that is active in rodent endotoxemia and pain models, although the dose required for pain relief is lower than the dose required for efficacy in an endotoxic shock model, suggesting some of its analgesic properties are likely to be inhibition of nNOS [74]. Here, NOS2 is linked to serum lipopolysaccharide activity.